Interim study suggests oral TXA is equally effective in preventing blood loss in joint replacement

Interim study suggests oral TXA is equally effective in preventing blood loss in joint replacement

Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in total knee and total hip replacement surgery. These findings were presented at the 2021 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting.1

Comments are closed.

CDC: COVID-19 vaccine can be given along with other shots
14 May 2021
Teens, adults who use E-cigarettes have increased odds of asthma, asthma attacks
14 May 2021